197 related articles for article (PubMed ID: 7859360)
1. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice.
Storer RD; Cartwright ME; Cook WO; Soper KA; Nichols WW
Carcinogenesis; 1995 Feb; 16(2):285-93. PubMed ID: 7859360
[TBL] [Abstract][Full Text] [Related]
2. Micronuclei induced in peripheral blood of E mu-PIM-1 transgenic mice by chronic oral treatment with 2-acetylaminofluorene or benzene but not with diethyl-nitrosamine or 1,2-dichloroethane.
Armstrong MJ; Galloway SM
Mutat Res; 1993 May; 302(1):61-70. PubMed ID: 7683108
[TBL] [Abstract][Full Text] [Related]
3. Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice.
Sørensen IK; Mortensen A; Kristiansen E; van Kreijl C; Adamson RH; Thorgeirsson SS
Carcinogenesis; 1996 Oct; 17(10):2221-7. PubMed ID: 8895492
[TBL] [Abstract][Full Text] [Related]
4. Use of E mu-PIM-1 transgenic mice short-term in vivo carcinogenicity testing: lymphoma induction by benzo[a]pyrene, but not by TPA.
Kroese ED; Dortant PM; van Steeg H; van Oostrom CT; van der Houven van Oordt CW; van Kranen HJ; de Vries A; Wester PW; van Kreijl CF
Carcinogenesis; 1997 May; 18(5):975-80. PubMed ID: 9163683
[TBL] [Abstract][Full Text] [Related]
5. Lymphoma induction by heterocyclic amines in E mu-pim-1 transgenic mice.
Sørensen IK; Kristiansen E; Mortensen A; van Kreijl C; Adamson RH; Thorgeirsson SS
Arch Toxicol Suppl; 1997; 19():377-86. PubMed ID: 9079225
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Emu-pim-1 transgenic mouse model for short-term carcinogenicity testing.
van Kreijl CF; van der Houven van Oordt CW; Kroese ED; Sørensen IK; Breuer ML; Storer RD
Toxicol Pathol; 1998; 26(6):750-6. PubMed ID: 9864091
[TBL] [Abstract][Full Text] [Related]
7. X-ray-induced lymphomagenesis in E mu-pim-1 transgenic mice: an investigation of the co-operating molecular events.
van der Houven van Oordt CW; Schouten TG; van Krieken JH; van Dierendonck JH; van der Eb AJ; Breuer ML
Carcinogenesis; 1998 May; 19(5):847-53. PubMed ID: 9635873
[TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
[TBL] [Abstract][Full Text] [Related]
9. Exposure to 60 Hz magnetic fields and risk of lymphoma in PIM transgenic and TSG-p53 (p53 knockout) mice.
McCormick DL; Ryan BM; Findlay JC; Gauger JR; Johnson TR; Morrissey RL; Boorman GA
Carcinogenesis; 1998 Sep; 19(9):1649-53. PubMed ID: 9771937
[TBL] [Abstract][Full Text] [Related]
10. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.
Breuer M; Slebos R; Verbeek S; van Lohuizen M; Wientjens E; Berns A
Nature; 1989 Jul; 340(6228):61-3. PubMed ID: 2786994
[TBL] [Abstract][Full Text] [Related]
11. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice as a means to study synergism between oncogenes.
Berns A; Breuer M; Verbeek S; van Lohuizen M
Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
[TBL] [Abstract][Full Text] [Related]
13. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
14. Correlation between medium-term multi-organ carcinogenesis bioassay data and long-term observation results in rats.
Hagiwara A; Tanaka H; Imaida K; Tamano S; Fukushima S; Ito N
Jpn J Cancer Res; 1993 Mar; 84(3):237-45. PubMed ID: 8486526
[TBL] [Abstract][Full Text] [Related]
15. The Trp53 hemizygous mouse in pharmaceutical development: points to consider for pathologists.
Floyd E; Mann P; Long G; Ochoa R
Toxicol Pathol; 2002; 30(1):147-56. PubMed ID: 11890468
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of acrylonitrile (CAS No. 107-13-1) in B6C3F1 mice (gavage studies).
Natl Toxicol Program Tech Rep Ser; 2001 Oct; (506):1-201. PubMed ID: 11803701
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2003 May; (508):1-280. PubMed ID: 12844193
[TBL] [Abstract][Full Text] [Related]
18. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
19. Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study.
Koujitani T; Yasuhara K; Usui T; Nomura T; Onodera H; Takagi H; Hirose M; Mitsumori K
Cancer Lett; 2000 May; 152(2):211-6. PubMed ID: 10773414
[TBL] [Abstract][Full Text] [Related]
20. The genotoxicity of aromatic amines in primary hepatocytes isolated from C57BL/6 and DBA/2 mice.
Møller ME; Glowinski IB; Thorgeirsson SS
Carcinogenesis; 1984 Jun; 5(6):797-804. PubMed ID: 6722987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
